Cardinal Health, Inc. $CAH Shares Sold by AMF Tjanstepension AB

AMF Tjanstepension AB lowered its holdings in Cardinal Health, Inc. (NYSE:CAH) by 38.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 96,130 shares of the company’s stock after selling 61,050 shares during the quarter. AMF Tjanstepension AB’s holdings in Cardinal Health were worth $15,089,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. increased its position in shares of Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares in the last quarter. Atlantic Edge Private Wealth Management LLC grew its stake in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the last quarter. Vermillion & White Wealth Management Group LLC increased its position in Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after buying an additional 71 shares during the period. American Capital Advisory LLC lifted its stake in Cardinal Health by 5,200.0% in the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Finally, NewSquare Capital LLC lifted its stake in Cardinal Health by 100.0% in the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after buying an additional 107 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

CAH stock opened at $208.29 on Friday. The company’s 50 day simple moving average is $205.78 and its 200-day simple moving average is $176.26. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $215.48. The firm has a market capitalization of $49.49 billion, a PE ratio of 31.42, a P/E/G ratio of 1.41 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the firm earned $1.88 EPS. The firm’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were paid a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several recent research reports. UBS Group increased their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday. Jefferies Financial Group lifted their target price on Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft boosted their target price on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Finally, Mizuho set a $222.00 price target on Cardinal Health in a report on Monday, January 12th. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $221.07.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.